Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review

Dimitrios Rikos,Michail Vikelis,Emmanouil V. Dermitzakis,Panagiotis Soldatos,Dimitrios Rallis,Jobst Rudolf,Anna P. Andreou,Andreas A. Argyriou

Journal of Clinical Medicine（2024）

Cited 0|Views15

Key words

migraine,prevention,calcitonin gene-related peptide (CGRP),monoclonal antibody,quality,risk of bias,randomized clinical trials,erenumab,fremanezumab,galcanezumab,eptinezumab

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined